These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9315751)
1. From the Food and Drug Administration. Nightingale SL JAMA; 1997 Oct; 278(13):1054. PubMed ID: 9315751 [No Abstract] [Full Text] [Related]
2. Capitol Hill panelists want FDA intervention in DTC drug advertising. Med Health; 2005 Oct; 59(36):1, 6, 8. PubMed ID: 16238177 [No Abstract] [Full Text] [Related]
3. New DTC guidelines please drug companies, anger critics. Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080 [No Abstract] [Full Text] [Related]
4. From the Food and Drug Administration. Nightingale SL JAMA; 1995 Oct; 274(14):1109. PubMed ID: 7563473 [No Abstract] [Full Text] [Related]
5. My stand against DTC ads. Bellard BM Med Econ; 2004 Feb; 81(4):104. PubMed ID: 15015419 [No Abstract] [Full Text] [Related]
6. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related]
7. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead. Hayes TA Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174 [No Abstract] [Full Text] [Related]
8. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Macias W; Pashupati K; Lewis LS Health Commun; 2007; 22(3):241-52. PubMed ID: 17967146 [TBL] [Abstract][Full Text] [Related]
10. FDA issues import alert against unapproved mail-order drugs. Am J Hosp Pharm; 1992 May; 49(5):1024. PubMed ID: 1595726 [No Abstract] [Full Text] [Related]
11. From the Food and Drug Administration. Nightingale SL JAMA; 1998 Mar; 279(9):645. PubMed ID: 9496968 [No Abstract] [Full Text] [Related]
12. Drug promotion. Stryer DB; Bero LA N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7885416 [No Abstract] [Full Text] [Related]
13. From the Food and Drug Administration. Crawford LM JAMA; 2002 Jul; 288(1):36. PubMed ID: 12090852 [No Abstract] [Full Text] [Related]
14. Drug firms vow to tone down consumer advertisements. Wadman M Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559 [No Abstract] [Full Text] [Related]
15. Is the information "fair and balanced" in direct-to-consumer prescription drug websites? Huh J; Cude BJ J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic-class wars--drug promotion in a competitive marketplace. Kessler DA; Rose JL; Temple RJ; Schapiro R; Griffin JP N Engl J Med; 1994 Nov; 331(20):1350-3. PubMed ID: 7935706 [No Abstract] [Full Text] [Related]
17. FDA tells drug and device makers to give balanced picture of risks in ads, labels. Kuehn BM JAMA; 2009 Jun; 301(24):2541. PubMed ID: 19549965 [No Abstract] [Full Text] [Related]
18. The strange allure of state "right-to-try" laws. Zettler PJ; Greely HT JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589 [No Abstract] [Full Text] [Related]
19. Adderall and the FDA. Diller LH J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):737. PubMed ID: 11437005 [No Abstract] [Full Text] [Related]
20. Coming to terms with direct-to-consumer advertising. Curtis LG JAAPA; 2002 Jan; 15(1):6, 9. PubMed ID: 11845633 [No Abstract] [Full Text] [Related] [Next] [New Search]